{"title": "Beatriz Artalejo en LinkedIn: Balance anual de la EMA 2022: nuevas vacunas y f\u00e1rmacos que traen \u201cun\u2026", "author": "Beatriz Artalejo", "url": "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I", "hostname": "linkedin.com", "description": "Balance anual de la EMA 2022: nuevas vacunas y f\u00e1rmacos que traen \u201cun cambio incalculable\u201d", "sitename": "Linkedin", "date": "2023-05-17", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[](https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_feed-actor-image)\nPharmaceutical Scientific Officer and GMP Technical Director IQS Tech Transfer\n[](https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Felglobal%2Ees%2Fpolitica%2Fbalance-anual-de-la-ema-2022-nuevas-vacunas-y-farmacos-que-traen-un-cambio-incalculable%2F&urlhash=J088&trk=public_post_feed-article-content)\nLinkedIn y terceros utilizan cookies imprescindibles y opcionales para ofrecer, proteger, analizar y mejorar nuestros servicios, y para mostrarte publicidad relevante (incluidos anuncios profesionales y de empleo) dentro y fuera de LinkedIn. Consulta m\u00e1s informaci\u00f3n en nuestra\n[Pol\u00edtica de cookies](https://www.linkedin.com/legal/cookie-policy).\nSelecciona Aceptar para consentir o Rechazar para denegar las cookies no imprescindibles para este uso. Puedes actualizar tus preferencias en cualquier momento en tus\n[ajustes](https://www.linkedin.com/mypreferences/g/guest-cookies).\nPharmaceutical Scientific Officer and GMP Technical Director IQS Tech Transfer\nPara ver o add a comment,\n[inicia sesi\u00f3n](https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_feed-cta-banner-cta)\n5525 seguidores", "language": null, "image": "https://media.licdn.com/dms/image/sync/D5627AQEldClt3b6iXw/articleshare-shrink_1280_800/0/1690668836923?e=1696248000&v=beta&t=GFCBx2c4UhHlhYQMOxrJX6D0y7Ri-25f51CUJVm7Jgc", "pagetype": "article", "links": ["https://www.linkedin.com/legal/cookie-policy", "https://www.linkedin.com/mypreferences/g/guest-cookies", "#main-content", "/?trk=public_post_nav-header-logo", "https://www.linkedin.com/pulse/topics/home/?trk=public_post_guest_nav_menu_articles", "https://www.linkedin.com/pub/dir/+/+?trk=public_post_guest_nav_menu_people", "https://www.linkedin.com/learning/search?trk=public_post_guest_nav_menu_learning", "https://www.linkedin.com/jobs/search?trk=public_post_guest_nav_menu_jobs", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_nav-header-join", "https://www.linkedin.com/login?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&fromSignIn=true&trk=public_post_nav-header-signin", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Felglobal%2Ees%2Fpolitica%2Fbalance-anual-de-la-ema-2022-nuevas-vacunas-y-farmacos-que-traen-un-cambio-incalculable%2F&urlhash=J088&trk=public_post_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fposts%2Fbeatriz-artalejo-b819b713_balance-anual-de-la-ema-2022-nuevas-vacunas-activity-7064600657856503808-pf3I&trk=public_post_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_la-visi%C3%B3n-a-corto-plazo-lastra-la-transformaci%C3%B3n-activity-7111055879323422720-fhBt", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-visi%25C3%25B3n-a-corto-plazo-lastra-la-transformaci%25C3%25B3n-activity-7111055879323422720-fhBt&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fdiariofarma%2Ecom%2F2023%2F09%2F21%2Fla-vision-a-corto-plazo-lastra-la-transformacion-del-sns&urlhash=Su5H&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-visi%25C3%25B3n-a-corto-plazo-lastra-la-transformaci%25C3%25B3n-activity-7111055879323422720-fhBt&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-visi%25C3%25B3n-a-corto-plazo-lastra-la-transformaci%25C3%25B3n-activity-7111055879323422720-fhBt&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-visi%25C3%25B3n-a-corto-plazo-lastra-la-transformaci%25C3%25B3n-activity-7111055879323422720-fhBt&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_novo-nordisk-prev%C3%A9-abrir-una-sede-tecnol%C3%B3gica-activity-7110618768543784960-jPJ1", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_novo-nordisk-prev%25C3%25A9-abrir-una-sede-tecnol%25C3%25B3gica-activity-7110618768543784960-jPJ1&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Eplantadoce%2Ecom%2Fempresa%2Fnovo-nordisk-preve-abrir-una-sede-tecnologica-y-digital-en-espana%2Ehtml&urlhash=qMSb&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_novo-nordisk-prev%25C3%25A9-abrir-una-sede-tecnol%25C3%25B3gica-activity-7110618768543784960-jPJ1&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_novo-nordisk-prev%25C3%25A9-abrir-una-sede-tecnol%25C3%25B3gica-activity-7110618768543784960-jPJ1&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_novo-nordisk-prev%25C3%25A9-abrir-una-sede-tecnol%25C3%25B3gica-activity-7110618768543784960-jPJ1&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_novo-nordisk-prev%25C3%25A9-abrir-una-sede-tecnol%25C3%25B3gica-activity-7110618768543784960-jPJ1&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_el-parlamento-europeo-estima-que-la-reforma-activity-7110618349461516288-rQST", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-parlamento-europeo-estima-que-la-reforma-activity-7110618349461516288-rQST&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Felglobal%2Ees%2Fpolitica%2Fel-parlamento-europeo-estima-que-la-reforma-de-la-legislacion-farmaceutica-permita-un-15-mas-de-acceso-a-medicamentos%2F&urlhash=RvuY&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-parlamento-europeo-estima-que-la-reforma-activity-7110618349461516288-rQST&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-parlamento-europeo-estima-que-la-reforma-activity-7110618349461516288-rQST&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-parlamento-europeo-estima-que-la-reforma-activity-7110618349461516288-rQST&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%C3%B3n-del-plan-activity-7110617999190953985-G3eE", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%25C3%25B3n-del-plan-activity-7110617999190953985-G3eE&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fdiariofarma%2Ecom%2F2023%2F09%2F21%2Flos-expertos-piden-la-actualizacion-del-plan-de-cart-tras-cinco-anos-de-exito&urlhash=Idst&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%25C3%25B3n-del-plan-activity-7110617999190953985-G3eE&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%25C3%25B3n-del-plan-activity-7110617999190953985-G3eE&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%25C3%25B3n-del-plan-activity-7110617999190953985-G3eE&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_los-expertos-piden-la-actualizaci%25C3%25B3n-del-plan-activity-7110617999190953985-G3eE&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_d%C3%ADamundialdelalzheimer-activity-7110591058547216385-s_tX", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_d%25C3%25ADamundialdelalzheimer-activity-7110591058547216385-s_tX&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://es.linkedin.com/company/farmaindustria?trk=public_post_main-feed-card_reshare_feed-actor-image", "https://es.linkedin.com/company/farmaindustria?trk=public_post_main-feed-card_reshare_feed-actor-name", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Ffeed%2Fhashtag%2FdAeDamundialdelalzheimer&trk=public_post_main-feed-card_reshare-text", "https://es.linkedin.com/company/sociedad-espanola-de-neurologia?trk=public_post_main-feed-card_reshare-text", "https://lnkd.in/dmipMAR2?trk=public_post_main-feed-card_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_d%25C3%25ADamundialdelalzheimer-activity-7110591058547216385-s_tX&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_d%25C3%25ADamundialdelalzheimer-activity-7110591058547216385-s_tX&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_d%25C3%25ADamundialdelalzheimer-activity-7110591058547216385-s_tX&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_d%25C3%25ADamundialdelalzheimer-activity-7110591058547216385-s_tX&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%C3%ADa-mundial-activity-7109750466107850752-T8Xv", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%25C3%25ADa-mundial-activity-7109750466107850752-T8Xv&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://es.linkedin.com/company/farmaindustria?trk=public_post_main-feed-card_reshare_feed-actor-image", "https://es.linkedin.com/company/farmaindustria?trk=public_post_main-feed-card_reshare_feed-actor-name", "https://lnkd.in/dCuGXK86?trk=public_post_main-feed-card_reshare-text", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%25C3%25ADa-mundial-activity-7109750466107850752-T8Xv&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%25C3%25ADa-mundial-activity-7109750466107850752-T8Xv&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%25C3%25ADa-mundial-activity-7109750466107850752-T8Xv&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-domingo-17-hemos-celebrado-el-d%25C3%25ADa-mundial-activity-7109750466107850752-T8Xv&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_inteligencia-artificial-contra-las-enfermedades-activity-7108557247428911104-fZmv", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_inteligencia-artificial-contra-las-enfermedades-activity-7108557247428911104-fZmv&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fdiariofarma%2Ecom%2F2023%2F09%2F15%2Finteligencia-artificial-contra-las-enfermedades-raras&urlhash=lzzP&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_inteligencia-artificial-contra-las-enfermedades-activity-7108557247428911104-fZmv&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_inteligencia-artificial-contra-las-enfermedades-activity-7108557247428911104-fZmv&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_inteligencia-artificial-contra-las-enfermedades-activity-7108557247428911104-fZmv&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_el-gasto-p%C3%BAblico-en-medicamentos-y-ppss-sigue-activity-7108557111697010688-HItN", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-gasto-p%25C3%25BAblico-en-medicamentos-y-ppss-sigue-activity-7108557111697010688-HItN&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fdiariofarma%2Ecom%2F2023%2F09%2F14%2Fel-gasto-publico-en-medicamentos-y-ppss-sigue-bajando-respecto-del-pib&urlhash=z3Rm&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-gasto-p%25C3%25BAblico-en-medicamentos-y-ppss-sigue-activity-7108557111697010688-HItN&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-gasto-p%25C3%25BAblico-en-medicamentos-y-ppss-sigue-activity-7108557111697010688-HItN&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_el-gasto-p%25C3%25BAblico-en-medicamentos-y-ppss-sigue-activity-7108557111697010688-HItN&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fdiariofarma%2Ecom%2F2023%2F09%2F14%2Ffarmaindustria-pide-que-profarma-valore-las-inversiones-en-datos-y-la-subcontratacion-de-produccion&urlhash=nkMX&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_la-industria-pide-que-profarma-valore-las-activity-7108557009213374464-TvhG&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/posts/beatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%C3%B3n-gen%C3%A9rica-activity-7107628210640556034-7AEa", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-image", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_main-feed-card_feed-actor-name", "https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%25C3%25B3n-gen%25C3%25A9rica-activity-7107628210640556034-7AEa&trk=public_post_main-feed-card_ellipsis-menu-semaphore-sign-in-redirect&guestReportContentType=POST&_f=guest-reporting", "https://www.linkedin.com/redir/redirect?url=https%3A%2F%2Fwww%2Eplantadoce%2Ecom%2Fempresa%2Fsandoz-estudia-lanzar-una-version-generica-del-medicamento-stelara-de-jj%2Ehtml&urlhash=N-wY&trk=public_post_main-feed-card_feed-article-content", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%25C3%25B3n-gen%25C3%25A9rica-activity-7107628210640556034-7AEa&trk=public_post_main-feed-card_social-actions-reactions", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%25C3%25B3n-gen%25C3%25A9rica-activity-7107628210640556034-7AEa&trk=public_post_main-feed-card_like-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%25C3%25B3n-gen%25C3%25A9rica-activity-7107628210640556034-7AEa&trk=public_post_main-feed-card_comment-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fwww.linkedin.com%2Fposts%2Fbeatriz-artalejo-b819b713_sandoz-estudia-lanzar-una-versi%25C3%25B3n-gen%25C3%25A9rica-activity-7107628210640556034-7AEa&trk=public_post_main-feed-card_feed-cta-banner-cta", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fes%2Elinkedin%2Ecom%2Fin%2Fbeatriz-artalejo-b819b713%2Frecent-activity%2F&trk=public_post_follow-posts", "https://es.linkedin.com/in/beatriz-artalejo-b819b713?trk=public_post_follow-view-profile", "https://www.linkedin.com/signup/cold-join?session_redirect=https%3A%2F%2Fes%2Elinkedin%2Ecom%2Ffeed%2Fupdate%2Furn%3Ali%3Aactivity%3A7064600657856503808&trk=public_post_follow", "https://about.linkedin.com?trk=d_public_post_footer-about", "https://www.linkedin.com/accessibility?trk=d_public_post_footer-accessibility", "https://www.linkedin.com/legal/user-agreement?trk=d_public_post_footer-user-agreement", "https://www.linkedin.com/legal/privacy-policy?trk=d_public_post_footer-privacy-policy", "https://www.linkedin.com/legal/cookie-policy?trk=d_public_post_footer-cookie-policy", "https://www.linkedin.com/legal/copyright-policy?trk=d_public_post_footer-copyright-policy", "https://brand.linkedin.com/policies?trk=d_public_post_footer-brand-policy", "https://www.linkedin.com/psettings/guest-controls?trk=d_public_post_footer-guest-controls", "https://www.linkedin.com/legal/professional-community-policies?trk=d_public_post_footer-community-guide", null]}